[1]
“Omalizumab Withdrawal Protocol for Chronic Spontaneous Urticaria: Clinical Case”, Rev Alerg Mex, vol. 72, no. 3, p. 231, Sep. 2025, doi: 10.29262/ram.v72i3.1520.